Tag: Health Canada Special Access Program
Anteris marks first successful implantation of DurAVR THV heart valve
ASX-listed biotechnology company Anteris Technologies has announced the successful use of its DurAVR THV biomimetic valve in a valve-in-valve (ViV) procedure.
Featured Article
Balancing profit and sustainability in supply chains
Priorities in the supply chain are expanding, moving away from cost as the main driver behind purchasing decisions. Now, sustainability and ethical sourcing are grabbing a portion of the spotlight.
